Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPHET: Prophylactic Topical Epinephrine in Transbronchial Biopsy
NCT03126968Phase 3Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2017
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary hemorrhage comparing Prophylactic topical epinephrine with Placebo (2 arms). Primary endpoint: Intra-procedural Hemorrhage Grading by the Performing Bronchoscopist up to 48 hours. Started Jul 2017; status: completed.
02
Drugs
epinephrine nasal spray
03
Conditions
pulmonary hemorrhage
Beyond the preview
Go deeper on NCT03126968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03126968.